Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe record shows Active, not recruiting. Added Contacts/Locations, Study Design, Study Status, and Recruitment Status sections, with revision v3.3.2 dated 2025-11-19.SummaryDifference0.6%

- Check20 days agoChange DetectedNotice regarding government funding lapse and operating status, previously visible on the page, has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check34 days agoChange DetectedNo substantive changes to the trial's record history were observed between the old and new screenshots; the version list and study data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedMajor update: announces a funding-related operating status notice and a new version v3.2.0; replaces the earlier v3.1.0 release.SummaryDifference11%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check76 days agoChange DetectedNew date and a new Study Status Contacts/Locations entry added; an older timestamp removed, indicating updated contact/location information and status details.SummaryDifference1%

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.